User profiles for Akhila Balasubramanian

Akhila Balasubramanian

Postdoctoral Research Scientist, Eli Lilly and Company
Verified email at lilly.com
Cited by 133

Detection of hypermethylated genes in women with and without cervical neoplasia

Q Feng, A Balasubramanian, SE Hawes… - Journal of the …, 2005 - academic.oup.com
Background: DNA methylation changes are an early event in carcinogenesis and are often
present in the precursor lesions of various cancers. We examined whether DNA methylation …

Declining rates of osteoporosis management following fragility fractures in the US, 2000 through 2009

A Balasubramanian, LL Tosi, JM Lane, DR Dirschl… - JBJS, 2014 - journals.lww.com
Background: Clinical practice recommendations state that patients with fragility fractures
should be evaluated for osteoporosis and treated for the disease if it is present. The purpose of …

Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species–independent mitochondrial apoptotic pathway in Smad4 and p53 …

…, A Kasinathan, R Ganesan, A Balasubramanian… - Nutrition Research, 2018 - Elsevier
Curcumin is a natural dietary polyphenol compound that has various pharmacological activities
such as antiproliferative and cancer-preventive activities on tumor cells. Indeed, the role …

Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples

A Balasubramanian, SL Kulasingam… - Journal of lower …, 2010 - journals.lww.com
Objective. Estimate the accuracy and cost-effectiveness of cervical cancer screening strategies
based on high-risk human papillomavirus (HPV) DNA testing of self-collected vaginal …

[HTML][HTML] Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women

…, JM Sprafka, J Zhou, H Guo, A Balasubramanian… - Archives of …, 2018 - Springer
Studies examining real-world effectiveness of osteoporosis therapies are beset by limitations
due to confounding by indication. By evaluating longitudinal changes in fracture incidence, …

Completeness of prescription information in US commercial claims databases

JC Lauffenburger, A Balasubramanian… - … and drug safety, 2013 - Wiley Online Library
Purpose Pharmacy commercial claims databases are widely used for pharmacoepidemiologic
research. However, concerns have been raised that these databases may not fully …

Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions

A Balasubramanian, SW Wade, RA Adler… - Journal of Bone and …, 2018 - academic.oup.com
The purpose of this work was to evaluate systemic glucocorticoid exposure and fracture among
patients with newly‐diagnosed inflammatory and immune‐modulated conditions. Using …

The design and validation of a new algorithm to identify incident fractures in administrative claims data

…, ES Delzell, A Balasubramanian… - Journal of Bone and …, 2019 - academic.oup.com
Our study validated a claims‐based algorithm for the identification of incident and recurrent
fractures in administrative data. We used Centers for Medicare and Medicaid (CMS) claims …

Osteoporosis medication adherence: physician perceptions vs. patients' utilization

…, BS Stolshek, JL Adams, A Balasubramanian… - Bone, 2013 - Elsevier
Few data are available on physician perceptions of osteoporosis medication adherence.
This study compared physician-estimated medication adherence with adherence calculated …

Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan

…, J White, BS Stolshek, C Merinar, A Balasubramanian… - Bone, 2012 - Elsevier
The association between bisphosphonate adherence in the first 12months after therapy
initiation and subsequent fracture risk was examined. Patients were identified from a large, …